Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue

Journal of Chromatography B: Biomedical Applications

Volumn 709, Issue 2, 1998, Pages 289-295

  Mürdter, Thomas E ^a   Sperker, Bernhard ^a   Bosslet, Klaus ^b   Fritz, Peter ^a   Kroemer, Heyo K ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b Hoechst Marion Roussel PO B   (Germany)

Author keywords

Doxorubicin

Indexed keywords

DOXORUBICIN; PRODRUG;

ARTICLE; DRUG DETERMINATION; DRUG PURIFICATION; DRUG TISSUE LEVEL; FLUORESCENCE; HUMAN; HUMAN TISSUE; LUNG; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; GLUCURONATES; HUMANS; LUNG; LUNG NEOPLASMS; PERFUSION; PRODRUGS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SWINE;

EID: 0141810824     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(98)00079-6     Document Type: Article

References (20)

1. Bonadonna G. Clin. Trials J. 24(Suppl. 1):1987;3.
2. Shan A.M., Lincoff X., Young J.B. Ann. Int. Med. 125:1996;47.
3. Double J.A., Workman P.A. Cancer Treat. Rep. 61:1977;909.
4. Bachur N.R., Steele M., Meriwether M. J. Med. Chem. 19:1978;651.
5. De Jong J., Hüsken B.C.P., Beekman B., van der Vijgh W.J.F., Bast A. Eur. J. Pharm. Sci. 2:1994;229.
6. Cummings J., Stuart J.F.B., Calman K.C. J. Chromatogr. 311:1984;125.
7. Maessen P.A., Mross K.B., Pinedo H.M., Van der Vijgh W.J.F. J. Chromatogr. 417:1987;339.
8. Cox S.K., Wilke A.V., Frazier D. J. Chromatogr. 564:1991;322.
9. De Groot G., Tepas B.C.A., Storm G. J. Pharm. Biomed. Anal. 6:1988;927.
10. De Jong J., Guèrand W.S., Schoofs P.R., Bast A., Van der Vijgh W.J.F. J. Chromatogr. 570:1991;209.
11. Rossini L., Monti E., Cova D., Piccinini F. Arch. Toxicol. Suppl. 9:1986;474.
12. Maessen P.A., Pinedo H.M., Mross K.B., Van der Vijgh W.J.F. J. Chromatogr. 424:1988;103.
13. Rose M., Tillery K.F., El Dareer S.M., Hill D.L. J. Chromatogr. 425:1988;419.
14. B.A. Warren, in H.I. Peterson (Editor), Tumor Blood Circulation, CRC Press, Bocca Raton, FL, 1979, p. 1.
15. Bosslet K., Czech J., Hoffmann D. Tumor Targeting. 1:1995;45.
16. Linder A., Friedel G., Fritz P., Kivistö K.T., McClellan M., Toomes H. Thor. Cardiovasc. Surg. 44:1996;140.
17. J.C. Jaquesy, J.P. Gesson, C. Monneret, M. Mondon, B. Renoux, J.C. Florent, M. Koch, F. Tillequin, H.H. Sedlacek, M. Gerken, C. Kolar, G. Gaudel, K. Bosslet, J. Czech, D. Hoffmann, G. Seeman, H.U. Schorlemmer and G. Dickneite, EPA 92401218.0, 1992.
18. Leca F., Marchiset-Leca D., Noble A., Antonetti M. Drug Metab. Pharmacokin. 16:1991;107.
19. Loveless H., Arena E., Felsted R.L., Bachur N.R. Cancer Res. 38:1978;589.
20. Mürdter T.E., Sperker B., Kivistö K.T., McClellan M., Fritz P., Friedel G., Linder A., Bosslet K., Toomes H., Dierkesmann R., Kroemer H.K. Cancer Res. 57:1997;2440.